Journal Browser

Go Edit a Special Issue

Archive

Special Issue Title:

Opioid Free Analgesia: new concept, new trends

Deadline for manuscript submissions: 20 February 2022

Print Special Issue Flyer (18)

Special Issue Editor

  • Guest Editor

    Dr. Mohamed Adel AboelelaE-MailWebsite

    MD, Consultant of anesthesia and SICU, Mansoura university hospitals, Egypt. Lecturer of anesthesia and SICU, Faculty of medicine, Mansoura university, Egypt.

    Interests: Neuroanesthesia, Liver transplantation anesthesia

Special Issue Information

Analgesia is a one of the three corner stones in anesthesia field. Perioperative pain or lacking of adequate analgesia affects hemodynamics, recovery, prognosis and overall patient's experience to surgical practice. For long times, opioids took the upper hand in such use, but it isn't free of side effects and complications which may burden patient's safety. Using non opioid drugs, regional blocks gained popularity in recent decades with promising results. Also, trends of preemptive analgesia proved efficacy. Opioid free anesthesia (OFA) explored in many trials with superior results. Drugs like ketamine, lidocaine, dexmedetomedine, dexamethasone used as co-analgesics outside its original indications.

All of these drugs or techniques have systemic effects based on used drug, dose, route of administration, patient's age, gender and associated co-morbidities. Nevertheless, techniques of regional block considered invasive and may be associated with hazards even with ultrasound guidance. Placing catheters for epidural use or regional plane block may carry risk of infection or need special precautions in patients receiving anti-coagulants.

SO, the new concept now targeting to minimize drug use, and interventions. The question is, can we use operative, or anesthetic, or ventilation techniques to improve patients experience toward pain? Can we use simple drugs like vitamins to minimize the need to systemic analgesic drug? Can we omit opioids use in perioperative analgesia? This is considered our challenge in future days, and in this special issue.

We welcome articles, trials, commentaries exploring new trends and techniques in analgesia practice.

Keywords

Analgesia, Pain, Opioids, OFA, Regional block

Manuscript Submission Information

Manuscripts should be submitted online by submit system. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Original articles, case reports or comprehensive reviews are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Signa Viate is an international peer-reviewed open access journal published by MRE Press. As of January 2021, Signa Vitae will change to a bimonthly journal. Please visit the Instructions for Authors page before submitting a manuscript.The Article Processing Charge (APC) for publication in this open access journal is $1200. We normally offer a discount greater than 30% to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.

Share This Special Issue

Published Papers (2 papers)

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 0.5(2019) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences